Total-Body Positron Emission Tomography (PET) Imaging Market Global Report 2026

The total-body positron emission tomography (PET) imaging market size has grown rapidly in recent years. It will grow from $1.4 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to growth in oncology diagnostic imaging demand, expansion of nuclear medicine infrastructure in hospitals, increasing prevalence of cancer and chronic diseases, rising adoption of PET-CT hybrid imaging systems, development of radiotracer-based diagnostic techniques.

The total-body positron emission tomography (PET) imaging market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to rising demand for precision oncology and personalized medicine, increasing adoption of AI-driven diagnostic imaging workflows, growth in early disease detection and preventive healthcare screening, expansion of research in molecular imaging and drug development, and rising investment in advanced hospital imaging infrastructure. Major trends in the forecast period include increasing adoption of AI-assisted PET image reconstruction and interpretation, rising demand for total-body PET systems with ultra-wide field-of-view imaging, growing use of semiconductor-based detectors for higher sensitivity and resolution, expansion of hybrid PET-CT and PET-MRI diagnostic platforms, and increasing integration of cloud-based imaging data storage and analysis solutions.

The increasing prevalence of cancer is expected to propel the growth of the total-body positron emission tomography (PET) imaging market in the coming years. Cancer is a disease caused by uncontrolled growth of abnormal cells that can invade and damage surrounding tissues and spread throughout the body. Cancer is increasing partly due to rising exposure to risk factors such as tobacco, pollution, and unhealthy lifestyles, which damage cells and increase the likelihood of uncontrolled growth. Total-body positron emission tomography (PET) imaging helps in cancer management by providing a complete whole-body scan in a single session that detects cancerous activity early, identifies metastasis more precisely, and helps clinicians monitor treatment effectiveness with higher accuracy and speed. For instance, in May 2023, according to Melanoma Focus, a UK-based national charity, by 2038, the UK could record approximately 26,500 new melanoma skin cancer cases annually, up from the current 16,700 cases. Therefore, the increasing prevalence of cancer is driving the growth of the total-body positron emission tomography (PET) imaging market.

Major companies operating in the total-body positron emission tomography (PET) imaging market are focusing on developing advanced solutions such as whole-body molecular imaging systems to improve diagnostic accuracy, enable faster scanning, and enhance early disease detection across the entire body in a single scan. A whole-body molecular imaging system is an advanced medical imaging technology that captures detailed images of biological and metabolic processes throughout the entire body simultaneously, enabling early detection of diseases such as cancer, neurological disorders, and cardiovascular conditions. For instance, in December 2024, the UK government introduced a new total body PET (positron emission tomography) scanner designed to image a patient’s entire body in a single scan, with significantly higher sensitivity and faster performance than conventional PET systems, enabling earlier detection of cancer, dementia, and other diseases while using lower radiation doses.

In June 2025, GE HealthCare, a US-based medical technology company, partnered with Stanford Medicine to advance total-body positron emission tomography (PET) or computed tomography (CT) technology to improve diagnostic imaging, enhance scan efficiency, and strengthen clinical research capabilities. This collaboration aims to accelerate innovation in total-body PET/CT imaging to improve early disease detection, optimize patient care, and expand precision medicine research applications. Stanford Medicine is a US-based academic health system.

Major companies operating in the total-body positron emission tomography (pet) imaging market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Shanghai United Imaging Healthcare Co. Ltd., Koninklijke Philips N.V., Canon Medical Systems Corporation, Bruker Corporation, Mediso Medical Imaging Systems Ltd., MILabs B.V., MR Solutions Ltd., PETsys Electronics S.A., NorthStar Medical Radioisotopes.

North America was the dominant region in the total-body positron emission tomography (PET) imaging market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in total-body positron emission tomography (PET) imaging report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the total-body positron emission tomography (PET) imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The total-body positron emission tomography (PET) imaging market consists of revenues earned by entities by providing services such as whole-body metabolic imaging, clinical research and drug development support, and quantitative imaging and data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The total-body positron emission tomography (PET) The imaging market also includes sales of digital PET detector modules, time-of-flight (TOF) PET imaging systems, and radiopharmaceutical imaging solution integration systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The total-body positron emission tomography (PET) imaging market research report is one of a series of new reports that provides total-body positron emission tomography (PET) imaging market statistics, including total-body positron emission tomography (PET) imaging industry global market size, regional shares, competitors with a total-body positron emission tomography (PET) imaging market share, detailed total-body positron emission tomography (PET) imaging market segments, market trends and opportunities, and any further data you may need to thrive in the total-body positron emission tomography (PET) imaging industry. This total-body positron emission tomography (PET) imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.